Summary
This 8-K filing from Biogen Idec Inc. (BIIB) on February 18, 2014, announces a significant leadership transition. William D. Young, the current Chairman of the Board, has indicated his intention to retire at the conclusion of his current term, which concludes at the 2014 annual meeting of stockholders. This marks the end of his tenure and signals a change in the board's leadership. Following Mr. Young's retirement, Dr. Stelios Papadopoulos, a seasoned board member since 2008, has been appointed by the Board of Directors to assume the role of Chairman. This appointment is effective immediately upon Mr. Young's departure. Investors should note this change as it reflects a shift in board leadership, with Dr. Papadopoulos bringing his experience to guide the board's strategic oversight.
Key Highlights
- 1William D. Young, Chairman of the Board, will retire at the end of his current term.
- 2Mr. Young's retirement is scheduled for the 2014 annual meeting of stockholders.
- 3Dr. Stelios Papadopoulos has been appointed as the new Chairman of the Board.
- 4Dr. Papadopoulos's appointment as Chairman is effective upon Mr. Young's retirement.
- 5Dr. Papadopoulos has been a member of the Board of Directors since 2008.